GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (NAS:QDEL) » Definitions » Price-to-Free-Cash-Flow

QuidelOrtho (QuidelOrtho) Price-to-Free-Cash-Flow

: 39.33 (As of Today)
View and export this data going back to 1992. Start your Free Trial

As of today (2024-04-16), QuidelOrtho's share price is $41.45. QuidelOrtho's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.05. Hence, QuidelOrtho's Price-to-Free-Cash-Flow Ratio for today is 39.33.

The historical rank and industry rank for QuidelOrtho's Price-to-Free-Cash-Flow or its related term are showing as below:

QDEL' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.38   Med: 30.12   Max: 393
Current: 39.33

During the past 13 years, QuidelOrtho's highest Price-to-Free-Cash-Flow Ratio was 393.00. The lowest was 3.38. And the median was 30.12.

QDEL's Price-to-Free-Cash-Flow is ranked worse than
63.28% of 335 companies
in the Medical Devices & Instruments industry
Industry Median: 31.91 vs QDEL: 39.33

QuidelOrtho's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.48. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $1.05.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of QuidelOrtho was -91.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -56.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 1.90% per year.

During the past 13 years, QuidelOrtho's highest 3-Year average Free Cash Flow per Share Growth Rate was 447.40% per year. The lowest was -76.10% per year. And the median was 16.90% per year.


QuidelOrtho Price-to-Free-Cash-Flow Historical Data

The historical data trend for QuidelOrtho's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.16 13.86 11.29 6.61 69.46

QuidelOrtho Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.61 13.51 51.24 33.43 69.46

Competitive Comparison

For the Medical Devices subindustry, QuidelOrtho's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho Price-to-Free-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Price-to-Free-Cash-Flow falls into.



QuidelOrtho Price-to-Free-Cash-Flow Calculation

QuidelOrtho's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=41.45/1.054
=39.33

QuidelOrtho's Share Price of today is $41.45.
QuidelOrtho's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

QuidelOrtho  (NAS:QDEL) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


QuidelOrtho Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (QuidelOrtho) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Executives
Louise Brandy officer: SVP, Chief Information Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Patrick Klein officer: Chief Administrative Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Christopher M Smith director 125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Edward L. Michael director 618 SHERIDAN SQUARE, EVANSTON IL 60202
William J. Ferenczy officer: SVP, Cardio/Metabolic Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Werner Kroll officer: SVP, Research and Development 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Kenneth F Buechler director
Robert R. Schmidt director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tamara A. Ranalli officer: SVP, Molecular Bus. Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Stephen H. Wise director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Robert Joseph Bujarski officer: See Remarks C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Wilkins Joseph D Jr. director 82414 PUCCINI DRIVE, INDIO CA 92203
Michelle A. Hodges officer: SVP, General Counsel 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Douglas C Bryant director, officer: Chairman & CEO C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Joseph M Busky officer: Chief Financial Officer 1717 DEERFIELD ROAD, DEERFIELD IL 60015